Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-02-22 @ 5:22 PM
Study NCT ID:
NCT02912260
Status:
COMPLETED
Last Update Posted:
2025-12-23
First Post:
2016-09-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Sponsor:
Madrigal Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-18
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-23
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-19
First Submit QC Date:
None
Study First Post Date:
2016-09-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-09-30
Results First Submit QC Date:
None
Results First Post Date:
2025-12-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-18
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED